Astodrimer Sodium Nasal Spray versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blinded, Placebo-Controlled Trial

• Glavni autori: Stephen Winchester (Autor), Alex Castellarnau (Autor), Kashif Jabbar (Autor), Meera Nadir (Autor), Kapila Ranasinghe (Autor), Xavier Masramon (Autor), George R. Kinghorn (Autor), Isaac John (Autor), Jeremy R. A. Paull (Autor)
• Format: Knjiga
• Izdano: MDPI AG, 2024-09-01T00:00:00Z.
• Teme: article
• Online pristup: Connect to this object online.

Background/Objectives: Dendrimer-based astodrimer sodium nasal spray was assessed for its ability to reduce SARS-CoV-2 load in outpatients with COVID-19, which remains a severe illness for vulnerable groups. Methods: This was a randomised, double-blind, placebo-controlled clinical investigation eval...